Skip to main content
Premium Trial:

Request an Annual Quote

Epigenomics Signs up Turkish Distributor for Cancer Test

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Epigenomics said today that it has signed up the biomedical distributor Dateks to market its colorectal cancer test in Turkey.

Epigenomics said that Dateks will market the Epi proColon, a DNA methylation-based test that detects colorectal cancer in blood plasma by identifying the Septin 9 biomarker.

Even though Cancer Early Diagnosis and Screening Centers have been set up in most provinces and the Turkish Ministry of Health has implemented CRC screening standards, screening is still low, Epigenomics said. The company said that this has "severe consequences as colorectal cancer is highly curable when detected at an early [and] still localized stage."

Dateks CEO Süha Dere said in a statement that this blood test is "as simple clean solution" that "can be performed at any time and it does not require any preparation of the screened individual."
"We believe this test can help significantly to drive acceptance of colorectal cancer early detection in the Turkish population," Dere added.

Epigenomics currently markets the Epi proColon test directly in Germany, Austria, and Switzerland.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.